12-13634912-T-C

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_000834.5(GRIN2B):​c.1126-18255A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.035 in 152,336 control chromosomes in the GnomAD database, including 217 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.035 ( 217 hom., cov: 32)

Consequence

GRIN2B
NM_000834.5 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -1.37

Publications

7 publications found
Variant links:
Genes affected
GRIN2B (HGNC:4586): (glutamate ionotropic receptor NMDA type subunit 2B) This gene encodes a member of the N-methyl-D-aspartate (NMDA) receptor family within the ionotropic glutamate receptor superfamily. The encoded protein is a subunit of the NMDA receptor ion channel which acts as an agonist binding site for glutamate. The NMDA receptors mediate a slow calcium-permeable component of excitatory synaptic transmission in the central nervous system. The NMDA receptors are heterotetramers of seven genetically encoded, differentially expressed subunits including NR1 (GRIN1), NR2 (GRIN2A, GRIN2B, GRIN2C, or GRIN2D) and NR3 (GRIN3A or GRIN3B). The early expression of this gene in development suggests a role in brain development, circuit formation, synaptic plasticity, and cellular migration and differentiation. Naturally occurring mutations within this gene are associated with neurodevelopmental disorders including autism spectrum disorder, attention deficit hyperactivity disorder, epilepsy, and schizophrenia. [provided by RefSeq, Aug 2017]
GRIN2B Gene-Disease associations (from GenCC):
  • complex neurodevelopmental disorder
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen, Ambry Genetics
  • developmental and epileptic encephalopathy, 27
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • intellectual disability, autosomal dominant 6
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
  • autosomal dominant non-syndromic intellectual disability
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • infantile spasms
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.93).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.19 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GRIN2BNM_000834.5 linkc.1126-18255A>G intron_variant Intron 5 of 13 ENST00000609686.4 NP_000825.2 Q13224A0A8D9PHB2
GRIN2BNM_001413992.1 linkc.1126-18255A>G intron_variant Intron 6 of 14 NP_001400921.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GRIN2BENST00000609686.4 linkc.1126-18255A>G intron_variant Intron 5 of 13 1 NM_000834.5 ENSP00000477455.1 Q13224
GRIN2BENST00000630791.3 linkc.1126-18255A>G intron_variant Intron 6 of 14 5 ENSP00000486677.3 A0A0D9SFK0
GRIN2BENST00000636855.1 linkn.24-660A>G intron_variant Intron 1 of 1 5
GRIN2BENST00000714048.1 linkn.1126-18255A>G intron_variant Intron 5 of 12 ENSP00000519339.1

Frequencies

GnomAD3 genomes
AF:
0.0351
AC:
5348
AN:
152218
Hom.:
218
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00567
Gnomad AMI
AF:
0.0175
Gnomad AMR
AF:
0.0230
Gnomad ASJ
AF:
0.0498
Gnomad EAS
AF:
0.200
Gnomad SAS
AF:
0.112
Gnomad FIN
AF:
0.103
Gnomad MID
AF:
0.0443
Gnomad NFE
AF:
0.0267
Gnomad OTH
AF:
0.0325
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.0350
AC:
5337
AN:
152336
Hom.:
217
Cov.:
32
AF XY:
0.0405
AC XY:
3019
AN XY:
74478
show subpopulations
African (AFR)
AF:
0.00565
AC:
235
AN:
41592
American (AMR)
AF:
0.0229
AC:
351
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.0498
AC:
173
AN:
3472
East Asian (EAS)
AF:
0.200
AC:
1037
AN:
5178
South Asian (SAS)
AF:
0.110
AC:
532
AN:
4824
European-Finnish (FIN)
AF:
0.103
AC:
1096
AN:
10614
Middle Eastern (MID)
AF:
0.0374
AC:
11
AN:
294
European-Non Finnish (NFE)
AF:
0.0267
AC:
1816
AN:
68030
Other (OTH)
AF:
0.0331
AC:
70
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
259
518
777
1036
1295
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
74
148
222
296
370
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0322
Hom.:
530
Bravo
AF:
0.0273
Asia WGS
AF:
0.135
AC:
467
AN:
3476

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.93
CADD
Benign
0.12
DANN
Benign
0.38
PhyloP100
-1.4
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2160519; hg19: chr12-13787846; API